Cabio Biotech (Wuhan) Co., Ltd. (SHA:688089)
China · Delayed Price · Currency is CNY 8.59
+0.14 (1.66%)
Sep 2, 2026, 3:00 PM CST
Cabio Biotech (Wuhan) Market Cap
Cabio Biotech (Wuhan) has a market cap or net worth of 1.39 billion as of September 2, 2026. Its market cap has decreased by -69.71% in one year.
Market Cap
1.39B
Enterprise Value
1.22B
Revenue
313.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.59
ChartMarket Cap Chart
Since December 19, 2019, Cabio Biotech (Wuhan)'s market cap has decreased from 5.54B to 1.39B, a decrease of -74.91%. That is a compound annual growth rate of -18.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 1.39B | -64.20% |
| Dec 31, 2025 | 3.88B | 21.24% |
| Dec 31, 2024 | 3.20B | 6.31% |
| Dec 29, 2023 | 3.01B | -44.60% |
| Dec 30, 2022 | 5.44B | -26.24% |
| Dec 31, 2021 | 7.37B | 55.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding